Determinants of the extent and duration of STAT3 signaling

References

• Groner B, Lucks P, Borghouts C. The function of Stat3 in tumor cells and their microenvironment. Semin Cell Dev Biol 2008; 19:341 - 50; http://dx.doi.org/10.1016/j.semcdb.2008.06.005; PMID: 18621135
   PubMed Web of Science ®Google Scholar
• Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9:798 - 809; http://dx.doi.org/10.1038/nrc2734; PMID: 19851315
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010; 39:493 - 506; http://dx.doi.org/10.1016/j.molcel.2010.07.023; PMID: 20797623
   PubMed Web of Science ®Google Scholar
• Ozenne P, Dayde D, Brambilla E, Eymin B, Gazzeri S. p14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway. Oncogene 2012; In press http://dx.doi.org/10.1038/onc.2012.107; PMID: 22450744
   PubMed Web of Science ®Google Scholar
• Wolsk E, Mygind H, Grøndahl TS, Pedersen BK, van Hall G. IL-6 selectively stimulates fat metabolism in human skeletal muscle. Am J Physiol Endocrinol Metab 2010; 299:E832 - 40; http://dx.doi.org/10.1152/ajpendo.00328.2010; PMID: 20823453
   PubMed Web of Science ®Google Scholar
• Borghouts C, Tittmann H, Delis N, Kirchenbauer M, Brill B, Groner B. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death. Mol Cancer Res 2010; 8:539 - 53; http://dx.doi.org/10.1158/1541-7786.MCR-09-0417; PMID: 20371673
   PubMed Web of Science ®Google Scholar
• Sansone P, Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 2012; 30:1005 - 14; http://dx.doi.org/10.1200/JCO.2010.31.8907; PMID: 22355058
   PubMed Web of Science ®Google Scholar
• Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995; 269:81 - 3; http://dx.doi.org/10.1126/science.7541555; PMID: 7541555
   PubMed Web of Science ®Google Scholar
• Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, et al. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ 1997; 8:1267 - 76; PMID: 9419415
   PubMedGoogle Scholar
• Oh ST, Gotlib J. JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms. Expert Rev Hematol 2010; 3:323 - 37; http://dx.doi.org/10.1586/ehm.10.28; PMID: 21082983
   PubMed Web of Science ®Google Scholar
• Scott LM. The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol 2011; 86:668 - 76; http://dx.doi.org/10.1002/ajh.22063; PMID: 21674578
   PubMed Web of Science ®Google Scholar
• Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 2007; 7:673 - 83; http://dx.doi.org/10.1038/nrc2210; PMID: 17721432
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009; 457:200 - 4; http://dx.doi.org/10.1038/nature07475; PMID: 19020503
   PubMed Web of Science ®Google Scholar
• Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, et al. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med 2011; 208:1359 - 66; http://dx.doi.org/10.1084/jem.20110283; PMID: 21690253
   PubMed Web of Science ®Google Scholar
• Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmäki H, Andersson EI, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366:1905 - 13; http://dx.doi.org/10.1056/NEJMoa1114885; PMID: 22591296
   PubMed Web of Science ®Google Scholar
• Meenhuis A, Irandoust M, Wölfler A, Roovers O, Valkhof M, Touw IP. Janus kinases promote cell-surface expression and provoke autonomous signalling from routing-defective G-CSF receptors. Biochem J 2009; 417:737 - 46; http://dx.doi.org/10.1042/BJ20081153; PMID: 18922133
   PubMed Web of Science ®Google Scholar
• Lee H, Deng J, Kujawski M, Yang C, Liu Y, Herrmann A, et al. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med 2010; 16:1421 - 8; http://dx.doi.org/10.1038/nm.2250; PMID: 21102457
   PubMed Web of Science ®Google Scholar
• Neiva KG, Zhang Z, Miyazawa M, Warner KA, Karl E, Nör JE. Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia 2009; 11:583 - 93; PMID: 19484147
   PubMed Web of Science ®Google Scholar
• Ancrile B, Lim KH, Counter CM. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 2007; 21:1714 - 9; http://dx.doi.org/10.1101/gad.1549407; PMID: 17639077
   PubMed Web of Science ®Google Scholar
• Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 2007; 117:3846 - 56; http://dx.doi.org/10.1172/JCI31871; PMID: 18060032
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883 - 99; http://dx.doi.org/10.1016/j.cell.2010.01.025; PMID: 20303878
   PubMed Web of Science ®Google Scholar
• Huang WL, Yeh HH, Lin CC, Lai WW, Chang JY, Chang WT, et al. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells. Mol Cancer 2010; 9:309; http://dx.doi.org/10.1186/1476-4598-9-309; PMID: 21122157
   PubMed Web of Science ®Google Scholar
• Kim DJ, Tremblay ML, Digiovanni J. Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation. PLoS One 2010; 5:e10290; http://dx.doi.org/10.1371/journal.pone.0010290; PMID: 20421975
   PubMed Web of Science ®Google Scholar
• Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, et al. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A 2009; 106:9435 - 40; PMID: 19478061
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H. SOCS, Inflammation, and Autoimmunity. Front Immunol 2012; 3:20; http://dx.doi.org/10.3389/fimmu.2012.00020; PMID: 22566904
   PubMed Web of Science ®Google Scholar
• He B, You L, Uematsu K, Zang K, Xu Z, Lee AY, et al. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A 2003; 100:14133 - 8; http://dx.doi.org/10.1073/pnas.2232790100; PMID: 14617776
   PubMed Web of Science ®Google Scholar
• Limnander A, Rothman PB. Abl oncogene bypasses normal regulation of Jak/STAT activation. Cell Cycle 2004; 3:1486 - 8; http://dx.doi.org/10.4161/cc.3.12.1297; PMID: 15611644
   PubMed Web of Science ®Google Scholar
• Hildebrand D, Walker P, Dalpke A, Heeg K, Kubatzky KF. Pasteurella multocida Toxin-induced Pim-1 expression disrupts suppressor of cytokine signalling (SOCS)-1 activity. Cell Microbiol 2010; 12:1732 - 45; http://dx.doi.org/10.1111/j.1462-5822.2010.01504.x; PMID: 20633028
   PubMed Web of Science ®Google Scholar
• Shuai K. Regulation of cytokine signaling pathways by PIAS proteins. Cell Res 2006; 16:196 - 202; http://dx.doi.org/10.1038/sj.cr.7310027; PMID: 16474434
   PubMed Web of Science ®Google Scholar
• Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs KD Jr., et al. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood 2010; 116:988 - 92; http://dx.doi.org/10.1182/blood-2010-02-270108; PMID: 20404132
   PubMed Web of Science ®Google Scholar
• Tran B, Dancey JE, Kamel-Reid S, McPherson JD, Bedard PL, Brown AM, et al. Cancer genomics: technology, discovery, and translation. J Clin Oncol 2012; 30:647 - 60; http://dx.doi.org/10.1200/JCO.2011.39.2316; PMID: 22271477
   PubMed Web of Science ®Google Scholar
• Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012; 44:760 - 4; http://dx.doi.org/10.1038/ng.2291; PMID: 22634756
   PubMed Web of Science ®Google Scholar
• Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, et al. Stat3 as an oncogene. Cell 1999; 98:295 - 303; http://dx.doi.org/10.1016/S0092-8674(00)81959-5; PMID: 10458605
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Lahesmaa R, Vahedi G, Laurence A, Kanno Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat Rev Immunol 2011; 11:239 - 50; http://dx.doi.org/10.1038/nri2958; PMID: 21436836
   PubMed Web of Science ®Google Scholar
• Eddahri F, Denanglaire S, Bureau F, Spolski R, Leonard WJ, Leo O, et al. Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood 2009; 113:2426 - 33; http://dx.doi.org/10.1182/blood-2008-04-154682; PMID: 19020307
   PubMed Web of Science ®Google Scholar
• Egwuagu CE. STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 2009; 47:149 - 56; http://dx.doi.org/10.1016/j.cyto.2009.07.003; PMID: 19648026
   PubMed Web of Science ®Google Scholar
• Liu X, Lee YS, Yu CR, Egwuagu CE. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J Immunol 2008; 180:6070 - 6; PMID: 18424728
   PubMed Web of Science ®Google Scholar
• Olson JA, Jameson SC. Keeping STATs on memory CD8+ T cells. Immunity 2011; 35:663 - 5; http://dx.doi.org/10.1016/j.immuni.2011.11.006; PMID: 22118521
   PubMed Web of Science ®Google Scholar
• Cui W, Liu Y, Weinstein JS, Craft J, Kaech SM. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 2011; 35:792 - 805; http://dx.doi.org/10.1016/j.immuni.2011.09.017; PMID: 22118527
   PubMed Web of Science ®Google Scholar
• Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 2011; 35:806 - 18; http://dx.doi.org/10.1016/j.immuni.2011.09.016; PMID: 22118528
   PubMed Web of Science ®Google Scholar
• Vafaizadeh V, Klemmt P, Brendel C, Weber K, Doebele C, Britt K, et al. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. Stem Cells 2010; 28:928 - 38; PMID: 20235097
   PubMed Web of Science ®Google Scholar
• Della Chiara G, Crotti A, Liboi E, Giacca M, Poli G, Lusic M. Negative regulation of HIV-1 transcription by a heterodimeric NF-κB1/p50 and C-terminally truncated STAT5 complex. J Mol Biol 2011; 410:933 - 43; http://dx.doi.org/10.1016/j.jmb.2011.03.044; PMID: 21763497
   PubMed Web of Science ®Google Scholar